VALN News and Press, Valneva SE From 08/12/25

Valneva SE (VALN) is expected to report $-0.27 for Q2 2025

2025-08-12 01:07:56 ET More on Valneva FDA lifts pause on Valneva's chikungunya vaccine in elderly CDC mulls travel notice for China amid rise in chikungunya cases Seeking Alpha’s Quant Rating on Valneva Historical earnings data for Valneva Fin...

2025-08-07 09:45:04 ET More on Valneva Valneva SE (VALN) Q1 2025 Earnings Call Transcript CDC mulls travel notice for China amid rise in chikungunya cases Valneva's chikungunya vaccine suspension gets lifted for older adults Seeking Alpha’s Quant Ratin...

2025-07-22 17:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-07-11 09:51:20 ET More on Valneva Valneva SE (VALN) Q1 2025 Earnings Call Transcript Valneva SE 2025 Q1 - Results - Earnings Call Presentation Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 Guidance CSL to replace Bavarian Nordic in Va...

2025-06-26 14:50:07 ET More on Valneva, Bavarian Nordic, etc. Bavarian Nordic A/S (BVNKF) Q1 2025 Earnings Call Transcript Bavarian Nordic A/S 2025 Q1 - Results - Earnings Call Presentation Valneva SE (VALN) Q1 2025 Earnings Call Transcript CDC vaccine panel ...

2025-05-20 07:44:15 ET More on Pfizer, Moderna, etc. Pfizer's Turnaround Story Is Stronger Than You Think Novavax, Inc. (NVAX) Presents at BofA Securities 2025 Health Care Conference (Transcript) Merck & Co., Inc. (MRK) BofA Securities 2025 Healthcare Conference ...

2025-05-19 00:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-05-10 07:57:38 ET More on Valneva Valneva SE (VALN) Q1 2025 Earnings Call Transcript Valneva SE 2025 Q1 - Results - Earnings Call Presentation Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 Guidance Valneva reports Q1 results V...

2025-05-09 09:47:36 ET Valneva SE (VALN) Q1 2025 Earnings Conference Call May 07, 2025 09:00 AM ET Company Participants Joshua Drumm - Vice President-Global Investor Relations Thomas Lingelbach - Chief Executive Officer Peter Bühler - Chief Financial Officer...